Skip to main content

Table 2 Association between early-pregnancy C-peptide and risk for GDM

From: Association between early-pregnancy serum C-peptide and risk of gestational diabetes mellitus: a nested case–control study among Chinese women

C-peptide

Case/Sample

Model 1a: OR (95% CI)

Model 2b: OR (95% CI)

Quartile 1

49/215

1.00

1.00

Quartile 2

58/224

1.12 (0.71, 1.76)

1.06 (0.66, 1.69)

Quartile 3

83/249

1.76 (1.15, 2.67)

1.52 (0.97, 2.36)

Quartile 4

142/308

3.06 (2.03, 4.61)

2.28 (1.43, 3.62)

Per 1 log ng/mL

332/996

3.21 (2.25, 4.58)

2.64 (1.76, 3.96)

Per 1 SD ng/mL

332/996

1.45 (1.27, 1.66)

1.33 (1.16, 1.54)

P for trendc

332/996

 < 0.001

 < 0.001

  1. CI confidence interval, GDM gestational diabetes mellitus, OR odds ratio, SD standard deviation
  2. aAdjusted for maternal age (continuous, years), gestational age (continuous, weeks), and education level (≤ 12 years and > 12 years)
  3. bAdjusted for smoking status (never, former, and current), alcohol consumption (never, former, and current), physical activity (continuous, MET-h∙week-1), pre-pregnancy BMI (continuous, kg/m2), parental history of diabetes (yes and no), history of gestational diabetes (yes and no), parity (0 and ≥ 1), and variables adjusted for in Model 1
  4. cLinear trend was estimated by replacing the values of C-peptide by the median value of each quartile, and modeling C-peptide as continuous variable in Model 2